eClinical Tech News

Incyte announced positive Phase 3 inMIND trial results for tafasitamab combined with lenalidomide and rituximab in relapsed or refractory...

Acticor Biotech, a clinical-stage biopharmaceutical company developing glenzocimab for cardiovascular emergencies, faces liquidation as the court-appointed administrator has requested...

Virpax Pharmaceuticals has announced an extension of its research agreement with the National Center for Advancing Translational Sciences (NCATS),...

Synedgen, Inc., a biotechnology company specializing in gastrointestinal disease treatment, has secured a $2.2 million contract from the Joint...

Precision BioSciences, a clinical-stage gene editing company, has announced a significant advancement in its quest to cure chronic hepatitis...

Medable, a leading clinical trial technology platform, has been recognized as a Trailblazer in Everest Group’s first-ever “Clinical Trial...

Terray Therapeutics, a biotechnology company revolutionizing small molecule drug development, has secured $120 million in Series B funding. This...

Clinical laboratories face a critical deadline: achieving Phase One compliance with the FDA’s Laboratory Developed Test (LDT) rule by...

Charles River Laboratories International, Inc. has introduced the Retrogenix® Non-Human Protein Library, a tool designed to assist biopharmaceutical companies...

Shionogi & Co., Ltd. has released new data from PROVE, a large-scale global study examining real-world evidence for Fetroja®/Fetcroja®...